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An 83‐year‐old man presented with dull pain in the left thorax and a mass shadow on the left (Fig. [1](#ccr31147-fig-0001){ref-type="fig"}). CT revealed a 22‐mm irregular opacity in the right upper lobe (Fig. [2](#ccr31147-fig-0002){ref-type="fig"}A) and a 30‐mm mass posterior to the left 8th rib (Fig. [2](#ccr31147-fig-0002){ref-type="fig"}B) without lymph node swelling. SUVmax was measured by FDG‐PET of the lung opacity, and the bone mass was 1.4 and 2.9, respectively. The radiologists diagnosed primary lung cancer with bone metastasis. However, CT performed 2 years previously had detected the same‐size lung opacity (Fig. [2](#ccr31147-fig-0002){ref-type="fig"}C) without the rib lesion (Fig. [2](#ccr31147-fig-0002){ref-type="fig"}D), suggesting a postinflammatory change.

![Chest X‐ray showing a mass shadow on the left (circled).](CCR3-5-1724-g001){#ccr31147-fig-0001}

![(A--B) Chest CT indicating a 22‐mm irregular opacity in the right upper lobe (A) and a 30‐mm mass in the rear side area of the left 8th rib (B). (C--D) Chest CT performed 2 years previously indicating the same size lung opacity (C) without the rib lesion (D).](CCR3-5-1724-g002){#ccr31147-fig-0002}

Question: What is the diagnosis for this bone mass?

A primary bone tumor (PBT) was considered as a differential diagnosis. Urinary Bence--Jones protein was positive, and a rib biopsy indicated plasmacytoma (Fig. [3](#ccr31147-fig-0003){ref-type="fig"}), which was confirmed by immunohistochemical staining. Bone marrow examination showed no abnormalities. Radiotherapy was given and a cytoreductive effect was obtained.

![Photomicrograph of the H&E‐stained rib biopsy showing neoplastic proliferation of plasma cells, which have a round or oval appearance.](CCR3-5-1724-g003){#ccr31147-fig-0003}

Primary bone tumors account for \<0.2% of all malignancies, and plasmacytoma accounts for 6.7% of PBTs. Despite the good local control with radiation therapy, a long‐term follow‐up is essential for patients with solitary plasmacytoma because about 50% of cases ultimately turn into overt multiple myeloma over 5 years [1](#ccr31147-bib-0001){ref-type="ref"}, [2](#ccr31147-bib-0002){ref-type="ref"}.
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